Lobbying

Association of Women in Rheumatology's latest lobbying report covers Q2 2025, at under $5,000. Its first report covers Q2 2023; the issues it reports most are Health Issues.

Association of Women in Rheumatology

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q2 2023
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

Association of Women in Rheumatology lobbying by quarter
Association of Women in Rheumatology lobbying by quarter
QuarterAmountReports
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$0 · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports

Firms it paid

Firm
Hart Health Strategies$09 quarters

Former officials lobbying for it

Former position
ELENI VALANOSSenator Marco RubioQ2 2025

Lobbying reports

Filed by
25/07/10for Q2 2025Hart Health StrategiesUnder $5,000
25/04/18for Q1 2025Hart Health StrategiesUnder $5,000
25/01/05for Q4 2024Hart Health StrategiesUnder $5,000
24/10/10for Q3 2024Hart Health StrategiesUnder $5,000
24/07/21for Q2 2024Hart Health StrategiesUnder $5,000
24/04/22for Q1 2024Hart Health StrategiesUnder $5,000
24/01/19for Q4 2023Hart Health StrategiesUnder $5,000
23/10/21for Q3 2023Hart Health StrategiesUnder $5,000
23/07/18for Q2 2023Hart Health StrategiesUnder $5,000
23/04/13for Q2 2023Hart Health StrategiesUnder $5,000